AR-7 (Atypical Retinoid 7) is a potent and selective retinoic acid receptor α (RARα) antagonist and an enhancer of the chaperone-mediated autophagy (CMA).

AM580 (also named CD336, NSC608001, Ro 40-6055) is a stable retinobenzoic analog that is originally synthesized as a novel, potent and selective RARα agonist with IC50 and EC50 of 8 nM and 0.36 nM, respectively.

HX-531 is a novel and potent antagonist of retinoid X receptors (RXR) with an IC50 value of 18 nM.

CD437 is a novel and potent RARγ agonist.

Acitretin (also known as Etretin, RO 10-1670; Soriatane; Etretin; Neotigason) is a novel, potent, orally bioavailable, second generation retinoid used for psoriasis.

Magnolol (also called Dehydrodichavicol and 5,5′-Diallyl-2,2′-biphenyldiol) is a novel, naturally occuring and bioactive lignin isolated from the bark of the Houpu magnolia (Magnolia officinalis) which shows antifungal properties.

IRX5183 (NRX-195183, VTP-195183, AGN-195183) is a potent, selective, and orally bioavailable retinoid acid receptor (RAR) alpha agonist with potential antineoplastic activity.

WYC-209, a synthetic retinoid, is a retinoic acid receptor (RAR) agonist.

Tarenflurbil [(R)-Flurbiprofen], the R-enantiomer of flurbiprofen, is a novel and potent activator of c-Jun N terminal kinase.

Palovarotene (formerly RO-3300074; R-667) is a novel, potent and highly selective retinoic acid receptor gamma (RAR-γ) agonist that is being investigated as a potential treatment for emphysema.